Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				AEG35156-103 MDA 2005-0384, PMH 05-0452-C, NCT00363974


2.		A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				Over 18				Pharmaceutical / Industry				AEG35156-201 NCT00557596


3.		A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				AEG35156-202 NCT00558545

Last Modified: 7/10/2007 First Published: 7/23/2006


4.		Phase I Study of AEG35156 and Docetaxel in Patients With Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Closed				18 and over				Other				CAN-NCIC-IND166 NCT00357747, IND166

Last Modified: 5/20/2008 First Published: 8/24/2006


5.		Phase I Study of AEG35156 and Docetaxel in Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Closed				18 and over				Other				CAN-NCIC-IND166B NCT00372736, IND166B

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute